USOO5766598A United States Patent (19) 11 Patent Number: 5,766,598 Paoletti et al. 45) Date of Patent: Jun. 16, 1998 54 RECOMBINANTATTENUATED ALVAC Murphy. F., 1996. "Virus Taxonomy", in Fields Virology, CANARYPOXVIRUS EXPRESSION Third Edition, Fields et al., eds. Lippincott-Raven Publish WECTORS CONTAINING HETEROLOGOUS ers. Philadelphia, pp. 15-57. DNA SEGMENTS ENCODNG LENTWRAL Taylor et al., 1991. Vaccine 9(3):190-193. GENE PRODUCTS Berman et al., 1990, Nature 345:622-625. Girard et al., 1991 Proc. Natl. Acad. Sci., USA 88:542-546. 75 Inventors: Enzo Paoletti, Delmar; James Tartaglia. Schenectady; William Irvin Hu et al., 1986. Nature 320:537-540. Cox. Troy, all of N.Y. Ho et al., 1990, Eur, J. Immunol. 20:477-483. Virology, vol. 173, No. 1, issued Nov. 1989, S. Dallo et al. 73) Assignee: Wirogenetics Corporation, Troy, N.Y. "Humoral Immune Response Elicited by Highly Attenuated Variants of Vaccinia Virus and by an Attenuated Recombi nant Expressing HIV-1 Envelope Protein". pp. 323-328 21 Appl. No.: 303,275 (entire document). (22 Filed: Sep. 7, 1994 Virology, vol. 152, issued 1986. M.E. Perkus et al., “Inser tion and Deletion Mutants of Vaccinia Virus". pp. 285-297 Related U.S. Application Data (entire document). Nature, vol. 317, issued 31 Oct. 1985, R.M.L. Buller et al., 63 Continuation of Ser. No. 897,382, Jun. 11, 1992, abandoned, which is a continuation-in-part of Ser. No. 715,921, Jun. 14, "Decreased Virulence of Recombinant Vaccinia Virus 1991, abandoned, and Ser. No. 847,951, Mar. 6, 1992, which Expression Vectors is Associated With a Thymidine is a continuation-in-part of Ser. No. 713,967, Jun. 11, 1991, Kinase-Negative Phenotype", pp. 813-815 (entire docu which is a continuation-in-part of Ser. No. 666,056, Mar. 7, ment). 199. Journal of Virology, vol. 62. No. 12, issued Dec. 1988, H. (51) Int. Cl. ....................... A61K 39/12: A61K 39/295; Shida et al., “Effects and Virulences of Recombinant Vac A61K 39/21: A61K 39/275 cinia Viruses Derived From Attenuated Strains That Express 52 U.S. C. .................................... 424/199.1; 424/208.1: the Human T-Cell Leukemia Virus Type 1 Envelope Gene". 424/232.1; 424/2011; 435/320.1; 435/236: pp. 4474-4480 (entire document). 435/1723 Critical Reviews in Immunology, vol. 10, No. 1 issued 58) Field of Search ................................ 435/69.1, 172.3, 1990.J. Tartaglia et al., "Poxvirus-Based Vectors as Vaccine 435/235. 236, 237; 424/199.1, 202.1, 208.1. Candidates", pp. 13-30 (entire document). (Tartaglia 900). 209.1 Virology, vol. 188, No. 1, issued May 1992, J. Tartaglia et al., "NYVAC: A Highly Attenuated Strain of Vaccinia 56) References Cited Virus". pp. 217-232 (entire document). U.S. PATENT DOCUMENTS Hosmalin. A. Nara, P.L., Zweig, M., Lerche. N.W., Cease. K.B., Gard, E.A., Markham, P.D., Putney, S.D. Daniel, 5,093,258 3/1992 Cohen .................................. 435/235.1 M.D.. Desrosiers, R.C. and Berzofsky, J.A. J. Immunol. 5,174,993 12/1992 Paoletti ..................................... 424/89 146. 1667-1673 (1991). 5,180,675 1/1993 Prillien ... 435/235. 5,185,146 2/1993 Attenburger .............................. 424/89 (List continued on next page.) FOREIGN PATENT DOCUMENTS Primary Examiner-Laurie Scheiner WO 89/O3429 of 1989 WIPO Assistant Examiner-Jeffrey S. Parkin WOA Attorney, Agent, or Firm-Frommer Lawrence & Haug 89/O3429 4f1989 WIPO. LLP: William S. Frommer; Thomas J. Kowalski WOA 90/10693 9/1990 WIPO 57 ABSTRACT WOA 90/210. Of 1990 WIPO This invention is directed toward recombinant attenuated canarypox virus expression vectors containing exogenous OTHER PUBLICATIONS DNA segments encoding lentiviral gene products. A parental Turner, P.C. et al. (90) Current topics in Microbiol. Immu canarypox virus (Rentschler strain) was obtained and attenu no. 163: 125-151. ated through more than 200 serial passages on chick embryo Lerner. R.A. et al. (83) in: The Biology of Immunologic fibroblasts. A master viral seed was subjected to four suc Disease, eds. F.J. Dixon & D.W. Fisher, H.P. Publishing Co. cessive plaque purifications under agar and one plaque clone New York, NY, pp. 331-338. was amplified through five additional passages after which Wain-Hobson. S. et al. (85) Cell 40:9-17. the stock virus was used as the parental virus in in vitro Cooney. E.L. et al. (91) Lancet 337:567-572. recombination studies. This attenuated plaque purified Tartaglia, J. et al. (906) in: Immunochemistry of Viruses, canarypox isolate was designated ALVAC. A series of eds. M.H.V. van Regenwortel and A.R. Newrath, Elsevier ALVAC recombinants were generated that are capable of Science Publishers B.V. pp. 125-151. expressing different HTV and SIV gene products including Norley, S. et al. Immunobiology 184: 193-207 (1992). Gag, Pol, Env, and Nef. These recombinants provide useful Cohen, J. et al. Science 262: 980-81 (1993). reagents for the generation of viral-specific immune Moss, B., 1996, "Poxviridae: The Viruses and Their Repli responses. cation" in Fields Virology, Third Edition, Fields et al., eds. Lippincott-Raven Publishers, Philadelphia, pp. 2637-2671. 14 Claims, 9 Drawing Sheets 5,766,598 Page 2 OTHER PUBLICATIONS Tartaglia.J. and Paoletti. E. In Immunochemistry of viruses, II, eds. van Regenmortel, M.H.V and Neurath, A.R., Letvin, N.L., and King. N.W..J. AIDS3. 1023-1040 (1990). McMichael, A.J., Gotch, F.M., Noble, G.R., and Beare, (Elsevier Science Publishers B.V., Amsterdam) pp. 125 P.A.S. New Engl. J. Med. 309, 13-17 (1983). (1990). Moss, D.J. Rickinson, A.B., and Pope, J.H., Int. J. Cancer Taylor, J. et al., Vaccine 6, 466-467 (1988). 22, 662-668 (1978). Taylor, J. et al., Vaccine 9, 190-193 (1991). Schmaljohn et al., Virology 155, 633–643 (1986). Taylor. J. Weinberg. R. Lanquet. B. Desmettre, P., and Schmitt et al., J. Virol. 62, 1889-1897 (1988). Paoletti, E. Vaccine 6, 497-503 (1988a). Tartaglia, J. Winslow, J. Goebel, S. Johnson, G.P. Taylor, Taylor, J. Weinberg, R. Kawaoka. Y. Webster. R.G. and J., and Paoletti, E. J. Gen. Virol. 71, 1517-1524 (1990). Paoletti, E. Vaccine 6, 504-508 (1988b). Tartaglia et al. Virology 188. 217-232 (1992). Walker. B.D., Flexner, C. Paradis, T.J., Fuller, T.C., Hirsch, Taylor et al. Virology 187, 321–328 (1992). M.S., Schooley, R.T. and Moss, B., Science 240. 64-66 Vos et al., EMBO J. 7, 3487-3492 (1988). (1988). Walker, B.D. and Plata. F. AIDS 4, 177-184 (1990). Nixon, D.F., Townsend, A.R.M., Elvin, J.G., Rizza, C.R., Walker, B.D., Chakrabarti, S. Moss, B. Paradi, T.J. Flynn. Gallwey, J. and McMichael, A.J. Nature 326, 484-487 T. Durno, A.G. Blumberg, R.S. Kaplan, J.C.. Hirsch, M.S. (1988). and Schooley, R.T., Nature 328.345-348 (1987). Panicali, D., and Paoletti, E. Proc. Natl. Acad. Sci. USA79, Walker, B.D. Flexner, C. Birch-Limberger, K. Fisher. L. 4927-4931 (1982). Paradis, T.J., Aldovini. A. Young. R. Moss. B., and Perkus, M.E. Piccini. A. Lipinskas. B.R. and Paoletti, E. Schooley, R.T., Proc. Natl. Acad. Sci. 86.9514-9519 Science 229,981-984 (1985). (1989). Perkus M.E. Goebe, S.J. Davis, S.W. Johnson, G.P., Weiss. R.A., Clapham, P.R. Cheingsong-Popov, R. Dal Limbach. K. Norton, E.K. and Paoletti. E. Virology 179. gleish, G., Carne, C.A.. Weller. I.V. and Tedder. R.S., 276-286 (1990). Nature 316. 69-72 (1985). Perkus, M.E., Limbach K., and Paoletti, E. J. Virol. 63. Yuen, L., and Moss, B. Proc. Natl. Acad. Sci. USA 84, 3829-3836 (1989). 6417-6421 (1987). Zagury, D., Bernard, J., Cheynier, R. Desportes, I., Leonard, Piccini, A., Perkus, M.E., and Paoletti, E. Methods in R. Fouchard, I. Reveil. B. Ittele, D. Lurhuma, Z., Mbayo, Enzymology 153, 545-563 (1987). K. Wane. J. Salaun, J.-J., Goussard, B. Dechazal, L., Plata, F. Autran, B. Martins, L.P. Wain-Hobson, S., Burny, A., Nara, P. and Gallo. R.C. Nature 332, 728-731 Raphael, M., Mayaud, C., Denis, M. Guillon, J.-M. Debre, (1988). P. Nature 328, 348-351 (1987). Zarling, J.M. Morton, W., Moran, PA. McClure, J. Ratner, L., Hasseltine, W., Patarca, R., Livak, K.J., Starcich, Kosowski. S.G. and Hu, S.-L. Nature 323, 344-346 B. Josephs. S.F. Doran, E.R. Rafalski, J.A., Whitehorn. (1986). E.A. Baumeister, K., Ivanoff, L. Petteway, Jr., S.R., Pear Autran, B., Plata, F., and Debre, P. J. AIDS 4, 361-367 son, M.L., Lautenberger. J.A. Papas, T.S. Ghrayeb, J., (1991). Chang N.T., Gallo. R.C., and Wong-Staal F. Nature 313, Borysiewicz, I., Graham, S. Hickling, J. Mason, P.D., and 277-284 (1985). Sissons. J.P.G. Eur. J. Immunology 18. 269-275 (1988). Rautmann, G. Kieny, M.-P. Brandely, R. Dott. K., Girard, Good, M.F. Maloy, W.L. Lunde, M.N., Margalit, H., Cor M. Montagnier, L. and Lecocg. J.-P. AIDS Research and nette, J.L., Smith, G.L., Moss, B. Miller, L.H., and Berzof Human Retroviruses 5, 147-157 (1989). sky, J.A., Science 235, 1059-1062 (1987). Riviere Y. Tanneau-Salvadori. F. Regnault. A. Lopez, O. Guo, P. Goebel, S. Davis. S. Perkus, M.E., Taylor, J., Sansonetti, P. Guy, B. Kieny, M.-P. Fournel, J.-J., and Norton, E. Allen, G. Lanquet, B. Desmettre, P. and Montagnier, L. J. Virol. 63. 2270-2277 (1989). Paoletti, E. J. virol. 174. 217-214 (1990).